Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236155 · ClinicalTrials.gov registry record · Phase 4
Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients
A Phase 4 study of Postoperative Pain, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 304
- Enrollment target
- 1
- Study location
NCT03236155 is a Phase 4 study of Postoperative Pain that has completed, run by Rush University Medical Center. The registered enrollment target is 304 participants, above the 227-participant average among 63 other Postoperative Pain trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03236155, a Phase 4 study of Postoperative Pain, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
The United States constitutes \<5% of the world's population but over 80% of the opioid supply and 99% of the hydrocodone supply. In 2014, there were 18,893 deaths from prescription drug overdose, and orthopaedic surgeons are the third highest prescribing physicians for opioids. Surgeons often prescribe opioids to minimize postoperative pain and to reduce the likelihood of readmission for pain. Available data suggests that orthopaedic surgeons are the most likely physicians to prescribe opioids to Medicare patients, whose opioid prescriptions are over 7 times more likely to come from an orthopaedic surgeon than another type of physician, but orthopaedic surgeons also had the highest readmission rate for post-operative pain. Many studies have investigated the utilization of opioids after surgery to assess surgeon's tendencies to overprescribe, demographics of those likely to overuse, and adverse events of opioid abusers. The primary purpose of this randomized controlled trial is to determine whether prescribing fewer opioid pills per prescription reduces the total amount of opioids taken, even while allowing equal total opioid availability via increased frequency of prescription availability.
Conditions Studied
Interventions
- DRUG opioid pain pills
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2018-08-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236155
The ClinicalTrials.gov registry entry for NCT03236155 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 227-participant average among 63 other Postoperative Pain trials with a reported enrollment target (34% higher). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which opioid pain pills is the first listed.
NCT03236155 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03236155 about?
NCT03236155 is a clinical study titled "Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients". The United States constitutes \<5% of the world's population but over 80% of the opioid supply and 99% of the hydrocodone supply. In 2014, there were 18,893 deaths from prescription drug overdose, and orthopaedic surgeons are the third highest prescribing physicians for opioids. Surgeons often presc...
What is the current status of trial NCT03236155?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 304 participants. The study started on 2017-07-01. Estimated completion is 2018-08-26.
What conditions does trial NCT03236155 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT03236155?
The interventions under investigation include: opioid pain pills (DRUG).
Who is sponsoring clinical trial NCT03236155?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03236155 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Single-shot TAP Block vs Continuous TAP Block
COMPLETED · Phase 4
-
Pain Control With Total Knee Replacement
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.